Neurological Complications of COVID-19: Underlying Mechanisms and Management

Ghaydaa A Shehata1, Kevin C Lord2, Michaela C Grudzinski3

  • 1Department of Neurology and Psychiatry, Assiut University Hospitals, Assiut 71511, Egypt.

Insights

COVID-19, caused by SARS-CoV-2, can lead to serious neurological complications. This review details the prevalence, pathogenesis, and management challenges of these neurological sequelae in COVID-19 patients.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Virology

Background:

  • COVID-19, a pandemic disease caused by SARS-CoV-2, primarily impacts the respiratory system.
  • Emerging evidence highlights significant neurological complications in patients with COVID-19.
  • These complications pose challenges for healthcare providers and require updated knowledge.

Purpose of the Study:

  • To review the prevalence and pathogenesis of neurological sequelae associated with SARS-CoV-2 infection.
  • To elucidate the mechanisms underlying COVID-19-related neurological disorders.
  • To provide an update for neurologists and healthcare workers on managing these neurological conditions.

Main Methods:

  • Literature review of studies reporting neurological complications in COVID-19 patients.
  • Analysis of reported neurological manifestations, including headache, dizziness, anosmia, encephalitis, and cerebrovascular events.
  • Examination of less common but severe complications such as seizures, neuromuscular disorders, and Guillain-Barré syndrome.

Main Results:

  • A wide spectrum of neurological complications is associated with COVID-19, ranging from common symptoms to severe conditions.
  • Pathogenesis involves direct viral invasion, inflammatory responses, and indirect effects on the nervous system.
  • Management strategies for these neurological sequelae are still evolving and present significant challenges.

Conclusions:

  • SARS-CoV-2 infection can result in diverse and complex neurological complications.
  • Understanding the mechanisms is crucial for developing effective therapeutic interventions.
  • Continuous updates and research are necessary for optimal patient care and management of neurological sequelae in COVID-19.

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.1K
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
2.1K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
554
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
45
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
382
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.5K